Page last updated: 2024-11-01

nitroglycerin and Pulmonary Arterial Hypertension

nitroglycerin has been researched along with Pulmonary Arterial Hypertension in 2 studies

Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.

Pulmonary Arterial Hypertension: A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.

Research Excerpts

ExcerptRelevanceReference
" Keywords used were "Pulmonary Hypertension", "Congenital heart defects", "Pediatrics", "Inhaled nitroglycerin", and its synonyms."9.12Nitroglycerin inhalation for acute treatment of pulmonary arterial hypertension in children with congenital heart disease. ( Marwali, EM; Rayhan, M; Roebiono, PS, 2021)
" Keywords used were "Pulmonary Hypertension", "Congenital heart defects", "Pediatrics", "Inhaled nitroglycerin", and its synonyms."5.12Nitroglycerin inhalation for acute treatment of pulmonary arterial hypertension in children with congenital heart disease. ( Marwali, EM; Rayhan, M; Roebiono, PS, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Marwali, EM1
Rayhan, M1
Roebiono, PS1
Nagano, T1
Ushijima, K1
Taga, N1
Takeuchi, M1
Kawada, MA1
Aizawa, K1
Imai, Y1
Fujimura, A1

Reviews

1 review available for nitroglycerin and Pulmonary Arterial Hypertension

ArticleYear
Nitroglycerin inhalation for acute treatment of pulmonary arterial hypertension in children with congenital heart disease.
    Cardiology in the young, 2021, Volume: 31, Issue:9

    Topics: Administration, Inhalation; Child; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Nitro

2021

Trials

1 trial available for nitroglycerin and Pulmonary Arterial Hypertension

ArticleYear
Influence of the aldehyde dehydrogenase 2 polymorphism on the vasodilatory effect of nitroglycerin in infants with congenital heart disease and pulmonary arterial hypertension.
    European journal of clinical pharmacology, 2019, Volume: 75, Issue:10

    Topics: Aldehyde Dehydrogenase, Mitochondrial; Female; Genotype; Heart Diseases; Humans; Infant; Male; Nitro

2019